Mergers & Acquisitions

  • October 02, 2025

    Del. Chancellor Advances Pruned $75B Activision Merger Suit

    Delaware's chancellor kept in play late Thursday much of an Activision Blizzard stockholder suit challenging the company's $75.4 billion merger with Microsoft, rejecting multiple dismissal motions, approving others and writing that a "slimmed-down" version of the complaint can go forward — adding, "Game on."

  • October 02, 2025

    Bain Inside Trade Claims Advance In Del. Cerevel Sale Suit

    Delaware's Court of Chancery on Thursday kept alive a pension funds suit alleging that private equity firm Bain Capital Investors LLC and others traded on inside information in the run-up to a secondary sale ahead of biopharmaceutical venture Cerevel Therapeutics Holdings Inc.'s $8.7 billion acquisition by AbbVie.

  • October 02, 2025

    Aramark, Vestis Can't Nix Investor Suit Over Spinoff's Woes

    Uniform supplier Vestis Corp. and food and facilities services giant Aramark can't shed proposed shareholder class action claims that they misled investors about Vestis' operations and customer relationships prior to its 2023 spinoff from Aramark.

  • October 02, 2025

    HNI Gives Enforcers More Time On $2.2B Steelcase Deal

    Workplace furnishing and residential building product manufacturer HNI Corp. has given antitrust enforcers additional time to review its planned $2.2 billion purchase of office, home and learning environment solutions maker Steelcase for potential competition concerns.

  • October 02, 2025

    Exec Says Beauty Co. Owes Her More After $1B L'Oreal Sale

    A beauty brand that L'Oreal bought for around $1 billion plans to share less of the proceeds with its president than what she is owed, according to an anticipatory breach of contract suit filed in Connecticut state court.

  • October 02, 2025

    Singaporean Biotech To Go Public Via $1.5B SPAC Merger

    Singapore-based biotechnology company Nanyang Biologics Pte. Ltd. on Thursday announced plans to go public in the U.S. by merging with special purpose acquisition company RF Acquisition Corp. II in a deal that gives the biotech a pre-transaction equity value of $1.5 billion.

  • October 02, 2025

    Jones Day Brings Back Latham M&A Pro In Silicon Valley

    Jones Day is boosting its corporate team, announcing Thursday that it is welcoming back a Latham & Watkins LLP mergers and acquisitions expert who started his career at Jones Day as a partner in its Silicon Valley office.

  • October 02, 2025

    Deals Rumor Mill: Global Infrastructure, Yahoo, MRI Software

    BlackRock's Global Infrastructure Partners is nearing a deal to take over utility company AES in a deal that could exceed $38 billion in value, Yahoo is reportedly ready to sell AOL to an Italian tech company for $1.4 billion, and private equity-backed real estate software company MRI Software is exploring options that could value it at up to $10 billion.

  • October 02, 2025

    Court Warned Of Harm From Delaying Medical Device Merger

    A D.C. federal court refused to pause the Federal Trade Commission's case challenging Edwards Lifesciences Corp.'s planned acquisition of JenaValve Technology Inc. during the government shutdown after the companies argued that "time is of the essence" for a new lifesaving medical device.

  • October 02, 2025

    Vet Co. Buyers Win $8M Interest On Top Of $40M Award In Del.

    A Delaware Superior Court judge has awarded buyers of what is now Veterinary Orthopedic Implants more than $8 million in prejudgment interest in a dispute over payouts still due after they won $40 million in a patent-related settlement, rejecting arguments the $8 million would amount to a double recovery.

  • October 02, 2025

    Musk Loses Bid To Ship SEC's Twitter Suit To Texas

    A U.S. Securities and Exchange Commission lawsuit accusing Elon Musk of failing to timely disclose his ownership shares in Twitter will proceed in a Washington, D.C., federal court after a judge there said on Thursday that Musk's preferred forum in Texas was too backed up to take the case.

  • October 02, 2025

    Cravath, Kirkland Lead Berkshire's $9.7B OxyChem Buy

    Warren Buffett's Berkshire Hathaway is set to acquire energy giant Occidental's chemical business, OxyChem, in a $9.7 billion all-cash megadeal built by Cravath Swaine & Moore LLP and Kirkland & Ellis LLP.

  • October 01, 2025

    FTC Halts Fraud Complaints, Spam Call Help Amid Shutdown

    The Federal Trade Commission said Wednesday that none of its mechanisms for reporting fraud, including identity theft, will be available to consumers while the federal government is shut down, nor will the National Do Not Call Registry be operational for consumers or telemarketers.

  • October 01, 2025

    Quantum Can't Nix FTC Order Over $5.2B Natural Gas Deal

    Quantum Energy Partners is not going to be allowed out from under a consent order it inked with the Federal Trade Commission that had allowed a $5.2 billion oil and gas deal with EQT Corp. to go through, the agency has announced.

  • October 01, 2025

    Russian Gets Docs Order Stay In Florida Trump Media Suit

    A Florida state court judge Wednesday paused his order compelling a Russian businessman with alleged financial ties to Donald Trump's Truth Social platform to respond to a subpoena in the lawsuit over taking the company public, saying the act of producing documents could constitute irreparable harm. 

  • October 01, 2025

    Charter Sued In Chancery For Docs On Liberty Deal

    A Charter Communications Inc. pension fund stockholder sued the company for documents on its proposed $17 billion buyout of Liberty Media on Wednesday, citing concerns that the controller of both companies lined up a "severely" overpriced deal at the expense of Charter's public investors.

  • October 01, 2025

    Monthly Merger Review Snapshot

    The Federal Trade Commission put the final tweaks on its deal allowing a $13.5 billion merger of marketing companies to move ahead and pushed its bid to block a merger in the medical device coatings industry, while U.K. enforcers launched a number of merger probes.

  • October 01, 2025

    Chancery Rules Beachbody Shareholder Suit Time-Barred

    A Delaware Chancery judge has dismissed a stockholder lawsuit accusing the backers of Forest Road Acquisition Corp. of misleading investors in their $3 billion merger with digital fitness and nutrition company Beachbody, ruling that the claims were brought more than three years too late.

  • October 01, 2025

    Va. Biz Group Calls Charter, Cox Tie-Up Good For Consumers

    The Virginia Chamber of Commerce urged the Federal Communications Commission to approve the planned $34.5 billion merger of cable giants Charter and Cox, saying it would be good for consumers as the companies cut costs through scale.

  • October 01, 2025

    Simpson Thacher Taps Barclays Atty For Shareholder Group

    Simpson Thacher & Bartlett LLP announced on Wednesday it has hired a former Barclays Capital attorney to lead its shareholder engagement and activism defense group.

  • October 01, 2025

    Weil, Morgan Lewis Steer Up To $900M Biopharma Purchase

    Biopharmaceutical company Halozyme Therapeutics Inc., led by Weil Gotshal & Manges LLP, on Wednesday announced plans to buy fellow biopharma company Elektrofi Inc., advised by Morgan Lewis & Bockius LLP, for up to $900 million.

  • October 01, 2025

    Skadden, MoFo Lead $4.4B All-Stock Merger Of Axcelis, Veeco

    Semiconductor production equipment company Axcelis Technologies Inc. on Wednesday announced plans to merge with Veeco Instruments Inc. in an all-stock deal that values the combined entity at an enterprise value of roughly $4.4 billion.

  • October 01, 2025

    3 Firms Guide Rocket Merger To Close With $14.2B Valuation

    Online mortgage giant Rocket has finished its all-stock purchase of rival Mr. Cooper Group with help from Paul Weiss, Wachtell and Bradley Arant, noting Wednesday the now-$14.2 billion deal has a higher price tag because stock values have risen since the merger's announcement.

  • October 01, 2025

    EU Clears Prada's €1.25B Deal To Buy Versace

    The European Commission has given the thumbs-up to Prada's acquisition of Italian designer brand Versace in a transaction worth approximately €1.25 billion ($1.47 billion).

  • September 30, 2025

    SEC Gives Stamp Of Approval To Texas Stock Exchange

    A Texas-based company hoping to rival the likes of the New York Stock Exchange overcame a major hurdle Tuesday when it won approval from the U.S. Securities and Exchange Commission to register its stock exchange.

Expert Analysis

  • Building Better Earnouts In The Current M&A Climate

    Author Photo

    In the face of market uncertainty, we've seen a continued reliance on earnouts in M&A deals so far this year, but to reduce the risk of related litigation, it's important to use objective standards, apply company metrics cautiously and ensure short time periods, among other best practices, say attorneys at White & Case.

  • Series

    Law School's Missed Lessons: Skillful Persuasion

    Author Photo

    In many ways, law school teaches us how to argue, but when the ultimate goal is to get your client what they want, being persuasive through preparation and humility is the more likely key to success, says Michael Friedland at Friedland Cianfrani.

  • A Look At Trump 2.0 Antitrust Enforcement So Far

    Author Photo

    The first six months of President Donald Trump's second administration were marked by aggressive antitrust enforcement tempered by traditional structural remedies for mergers, but other unprecedented actions, like the firing of Federal Trade Commission Democrats, will likely stoke heated discussion ahead, says Richard Dagen at Axinn.

  • Litigation Inspiration: How To Respond After A Loss

    Author Photo

    Every litigator loses a case now and then, and the sting of that loss can become a medicine that strengthens or a poison that corrodes, depending on how the attorney responds, says Bennett Rawicki at Hilgers Graben.

  • The Metamorphosis Of The Major Questions Doctrine

    Author Photo

    The so-called major questions doctrine arose as a counterweight to Chevron deference over the past few decades, but invocations of the doctrine have persisted in the year since Chevron was overturned, suggesting it still has a role to play in reining in agency overreach, say attorneys at Crowell & Moring.

  • Biotech Collaborations Can Ease Uncertainty Amid FDA Shift

    Author Photo

    As concerns persist that the U.S. Food and Drug Administration's reduced headcount will impede developments at already-strapped biotech companies, licensing and partnership transactions can provide the necessary funding and pathways to advance innovative products, say attorneys at Troutman.

  • Series

    Playing Mah-Jongg Makes Me A Better Mediator

    Author Photo

    Mah-jongg rewards patience, pattern recognition, adaptability and keen observation, all skills that are invaluable to my role as a mediator, and to all mediating parties, says Marina Corodemus.

  • Business Court Bill Furthers Texas' Pro-Corporate Strategy

    Author Photo

    The Texas Legislature's recent bill to enhance corporate protections and expand access to the Texas Business Court by refining its jurisdictional standards is just the latest step in the state's playbook for becoming the new center of corporate America, say attorneys at Katten.

  • FTC Staff Cuts Unlikely To Curb Antitrust Enforcement Agenda

    Author Photo

    While Federal Trade Commission Chair Andrew Ferguson's recent commitment to reducing agency staff may seem at odds with the Trump administration's commitment to antitrust enforcement, a closer analysis shows that such reductions have little chance of derailing the president's efforts, say attorneys at Squire Patton.

  • Series

    Law School's Missed Lessons: Navigating Client Trauma

    Author Photo

    Law schools don't train students to handle repeated exposure to clients' traumatic experiences, but for litigators practicing in areas like civil rights and personal injury, success depends on the ability to view cases clinically and to recognize when you may need to seek help, says Katie Bennett at Robins Kaplan.

  • Opinion

    4 Former Justices Would Likely Frown On Litigation Funding

    Author Photo

    As courts increasingly confront cases involving hidden litigation finance contracts, the jurisprudence of four former U.S. Supreme Court justices establishes a constitutional framework that risks erosion by undisclosed financial interests, says Roland Eisenhuth at the American Property Casualty Insurance Association.

  • Takeaways From EU's Review Of Merger Control Guidelines

    Author Photo

    The European Commission’s newly launched consultation on the European Union’s merger guidelines will explore whether and how merger control should consider key policy objectives, such as innovation, investment incentives and security, say lawyers at Latham.

  • How Attys Can Use AI To Surface Narratives In E-Discovery

    Author Photo

    E-discovery has reached a turning point where document review is no longer just about procedural tasks like identifying relevance and redacting privilege — rather, generative artificial intelligence tools now allow attorneys to draw connections, extract meaning and tell a coherent story, says Rose Jones at Hilgers Graben.

  • Identifying Data Center Investment Challenges, Opportunities

    Author Photo

    The role of data centers is expanding, as are new opportunities for private capital investors, but there are issues to consider, including finance models and contract complexity, as well as power supply, cyber threat resilience and data sovereignty, say lawyers at Ropes & Gray.

  • Leveraging Diligence Findings For Better Life Sciences Deals

    Author Photo

    Life sciences parties should utilize due diligence strategically to review and draft deal documents, address issues identified during the diligence, and craft solutions to achieve the party's transactional goals, says Anna Zhao at Gunner Cooke.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Mergers & Acquisitions archive.